HCA Healthcare, Inc. (HCA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 19.11B | 19.51B | 19.16B | 18.61B | 18.32B | 18.29B | 17.49B | 17.49B | 17.34B | 17.3B | 16.21B | 15.86B |
| Revenue Growth % | 4.3% | 6.72% | 9.57% | 6.36% | 5.66% | 5.68% | 7.86% | 10.28% | 11.21% | 11.65% | 8.3% | 7.02% |
| Cost of Goods Sold | 16.25B | 11.34B | 11.15B | 10.98B | 10.76B | 10.71B | 10.52B | 10.32B | 2.67B | 2.58B | 2.42B | 2.48B |
| COGS % of Revenue | 85.02% | 58.1% | 58.17% | 59.03% | 58.74% | 58.57% | 60.15% | 58.99% | 15.4% | 14.93% | 14.91% | 15.62% |
| Gross Profit | 2.86B | 8.18B | 8.02B | 7.62B | 7.56B | 7.58B | 6.97B | 7.17B | 14.67B | 14.72B | 13.8B | 13.38B |
| Gross Margin % | 14.98% | 41.9% | 41.83% | 40.97% | 41.26% | 41.43% | 39.85% | 41.01% | 84.6% | 85.07% | 85.09% | 84.38% |
| Gross Profit Growth % | -62.13% | 7.93% | 15.01% | 6.27% | -48.46% | -48.54% | -49.49% | -46.4% | 11.39% | 12.63% | 9.05% | 6.9% |
| Operating Expenses | 0 | 5B | 5.05B | 4.66B | 4.71B | 4.73B | 4.56B | 4.44B | 12.11B | 11.92B | 13.8B | 11.08B |
| OpEx % of Revenue | - | 25.61% | 26.36% | 25.03% | 25.68% | 25.86% | 26.07% | 25.39% | 69.83% | 68.88% | 85.09% | 69.88% |
| Selling, General & Admin | 8.28B | 0 | 0 | 7.86B | 8B | 7.92B | 7.86B | 7.68B | 7.71B | 7.57B | 7.56B | 7.28B |
| SG&A % of Revenue | 43.35% | - | - | 42.25% | 43.65% | 43.3% | 44.95% | 43.93% | 44.45% | 43.75% | 46.6% | 45.88% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | 1000K | 1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 2.86B | 3.18B | 2.96B | 2.97B | 2.85B | 2.85B | 2.41B | 2.73B | 2.56B | 2.8B | 0 | 2.3B |
| Operating Margin % | 14.98% | 16.29% | 15.47% | 15.95% | 15.58% | 15.56% | 13.78% | 15.61% | 14.76% | 16.19% | - | 14.5% |
| Operating Income Growth % | 0.28% | 11.67% | 23.03% | 8.64% | 11.52% | 1.61% | - | 18.74% | 5.18% | 16.08% | -100% | 0.17% |
| EBITDA | 3.79B | 4.09B | 3.85B | 3.83B | 3.71B | 3.7B | 3.25B | 3.55B | 3.35B | 3.59B | 2.88B | 3.06B |
| EBITDA Margin % | 19.85% | 20.96% | 20.11% | 20.59% | 20.28% | 20.25% | 18.6% | 20.29% | 19.35% | 20.75% | 17.78% | 19.31% |
| EBITDA Growth % | 2.1% | 10.45% | 18.51% | 7.89% | 10.73% | 3.12% | 12.84% | 15.9% | 5.17% | 13.5% | -0.35% | 0.96% |
| D&A (Non-Cash Add-back) | 930M | 911M | 889M | 863M | 860M | 856M | 842M | 819M | 795M | 789M | 769M | 763M |
| EBIT | 2.87B | 3.24B | 2.98B | 2.98B | 2.87B | 2.66B | 2.42B | 2.74B | 2.76B | 2.84B | 2.11B | 2.29B |
| Net Interest Income | -584M | -572M | -561M | -568M | -547M | -528M | -515M | -506M | -512M | -491M | -483M | -485M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 584M | 572M | 561M | 568M | 547M | 528M | 515M | 506M | 512M | 491M | 483M | 485M |
| Other Income/Expense | -576M | -506M | -547M | -552M | -528M | -713M | -504M | -494M | -313M | -456M | 1.63B | -491M |
| Pretax Income | 2.29B | 2.67B | 2.42B | 2.42B | 2.33B | 2.13B | 1.91B | 2.24B | 2.25B | 2.35B | 1.63B | 1.81B |
| Pretax Margin % | 11.97% | 13.69% | 12.62% | 12.98% | 12.7% | 11.67% | 10.9% | 12.79% | 12.96% | 13.55% | 10.05% | 11.41% |
| Income Tax | 430M | 509M | 515M | 524M | 502M | 447M | 424M | 550M | 445M | 484M | 355M | 397M |
| Effective Tax Rate % | 18.8% | 19.05% | 21.3% | 21.7% | 21.57% | 20.96% | 22.25% | 24.59% | 19.8% | 20.64% | 21.78% | 21.95% |
| Net Income | 1.62B | 1.88B | 1.64B | 1.65B | 1.61B | 1.44B | 1.27B | 1.46B | 1.59B | 1.61B | 1.08B | 1.19B |
| Net Margin % | 8.48% | 9.62% | 8.57% | 8.88% | 8.79% | 7.86% | 7.26% | 8.35% | 9.18% | 9.29% | 6.66% | 7.52% |
| Net Income Growth % | 0.62% | 30.6% | 29.37% | 13.14% | 1.19% | -10.52% | 17.7% | 22.46% | 16.73% | -22.78% | -4.85% | 3.29% |
| Net Income (Continuing) | 1.86B | 2.16B | 1.9B | 1.89B | 1.82B | 1.69B | 1.48B | 1.69B | 1.8B | 1.86B | 1.27B | 1.41B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.33B | 3.26B | 3.18B | 3.16B | 3.08B | 3.05B | 2.97B | 2.94B | 2.88B | 2.83B | 2.83B | 2.76B |
| EPS (Diluted) | 7.15 | 8.14 | 6.96 | 6.83 | 6.45 | 5.63 | 4.89 | 5.53 | 5.94 | 5.93 | 3.89 | 4.29 |
| EPS Growth % | 10.85% | 44.58% | 42.33% | 23.51% | 8.59% | -5.06% | 25.71% | 28.9% | 22.47% | -18.54% | -0.51% | 10% |
| EPS (Basic) | 7.15 | 8.14 | 7.05 | 6.91 | 6.52 | 5.70 | 4.94 | 5.60 | 6.04 | 6.05 | 3.92 | 4.35 |
| Diluted Shares Outstanding | 226.65M | 230.71M | 242.46M | 241.91M | 249.44M | 255.31M | 259.92M | 264.07M | 268.02M | 271.19M | 271.19M | 278.2M |
| Basic Shares Outstanding | 226.65M | 230.71M | 242.46M | 241.91M | 249.44M | 252.3M | 259.92M | 263.22M | 263.22M | 265.54M | 265.54M | 274.49M |
| Dividend Payout Ratio | 11.3% | 8.63% | 10.1% | 10.34% | 11.18% | 11.47% | 13.31% | 11.7% | 11.63% | 9.96% | 15.01% | 13.75% |